Chemoinformaics analysis of 2-Ethyl-p-xylene
| Molecular Weight | 134.222 | nRot | 1 |
| Heavy Atom Molecular Weight | 120.11 | nRig | 6 |
| Exact Molecular Weight | 134.11 | nRing | 1 |
| Solubility: LogS | -4.102 | nHRing | 0 |
| Solubility: LogP | 4.101 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 1 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 0 | APOL | 26.0351 |
| nHD | 0 | BPOL | 14.0449 |
| QED | 0.554 |
| Synth | 1.508 |
| Natural Product Likeliness | -0.873 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.039 |
| Pgp-sub | 0.007 |
| HIA | 0.005 |
| CACO-2 | -4.386 |
| MDCK | 0.0000222 |
| BBB | 0.915 |
| PPB | 0.936735 |
| VDSS | 1.951 |
| FU | 0.055161 |
| CYP1A2-inh | 0.94 |
| CYP1A2-sub | 0.947 |
| CYP2c19-inh | 0.768 |
| CYP2c19-sub | 0.853 |
| CYP2c9-inh | 0.402 |
| CYP2c9-sub | 0.601 |
| CYP2d6-inh | 0.73 |
| CYP2d6-sub | 0.917 |
| CYP3a4-inh | 0.224 |
| CYP3a4-sub | 0.517 |
| CL | 10.462 |
| T12 | 0.436 |
| hERG | 0.037 |
| Ames | 0.025 |
| ROA | 0.025 |
| SkinSen | 0.194 |
| Carcinogencity | 0.336 |
| EI | 0.995 |
| Respiratory | 0.042 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.917617 |